A case of minimal change glomerulopathy without interstitial nephritis induced by non-opiate analgesics

비마약성 진통제 복용 후 간질성 신염없이 발생된 미세변화 신증후군 1예

Li, Jae-Hoon;Shim, Hyeok;Yeom, Joo-Jin;Lee, Myeung-Su;Park, Byoung-Hyun;Oh, Seok-Kyu;Kim, Nam-Ho;Park, Moo-Rim;Ahn, Seon-Ho;Song, Ju-Hung
이재훈;심혁;염주진;이명수;박병현;오석규;김남호;박무림;안선호;송주흥

  • Published : 20020000

Abstract

The use of nonsteroidal antiinflammatory drugs (NSAIDs) can be complicated by severe forms of renal dysfunction. These include fluid and electrolyte abnormalities, acute renal insufficiency due to alteration in renal hemodynamics, or interstitial nephritis and proteinuria secondary to glomerular pathology, which has the histologic characteristics of minimal change glomerulopathy (MCG). While NSAID-induced nephrotic syndrome characteristically consists of MCG with interstitial nephritis, which is the most common clinical manifestation, it rarely consists of MCG without interstitial nephritis, which has been reported in a handful of patients who took fenoprofen, ibuprofen, sulindac, diclofenac, or zomepirac. We experienced a 66-year-old female patient who presented with low serum albumin, proteinuria and generalized edema and received $Geworin^{\circledR}$ for about 2 year before developing symptoms. She histologically had MCG without interstitial nephritis and achieved a complete remission thirty-fifth days after discontinuing the drug. A cause-and-effect relationship of this disease to $Geworin^{\circledR}$ administration is strongly suggested by the resolution of the proteinuria after the drug was stopped and by no evidence of any impairment in renal function after twenty eight months of follow-up.

현재 isopropylantipyrine을 함유하고 있는 혼합약물에서 acetaminophen의 효과만 강조되고 있고 있지만 isopropylantipyrine도 다른 NSAID와 동일한 기전으로 프로스그란딘 합성을 억제하여 신 부작용을 초래할 수 있다. 또한 NSAID 약물에 의한 미세변화 신증후군은 대부분 간질성 신염을 동반하는데, 간질성 신염없이 미세변화 신증후군만 발생하는 경우는 드물게 보고되고 있다. 저자들은 acetaminophen과 isopropylantipyrine의 혼합물인 $Geworin^{\circledR}$을 장기간 복용한 환자에서 간질성 신염없이 미세변화 신증후군을 경험하였기에 문헌고찰과 함께 보고한다.

Keywords

References

  1. Whelton A, Hamilton CW. Nonsteroidal antiinflammatory drugs: effect on kidney function. J Clin Pharmacol 31:588-598, 1991. https://doi.org/10.1002/j.1552-4604.1991.tb03743.x
  2. Kleinkencht D. Interstitial nephritis, the nephrotic syndrome and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs. Semin Nephrol 15:228-235, 1995.
  3. Sandler DP, Burr FR, Weinberg CR. Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Ann Intern Med 115:165-172, 1991. https://doi.org/10.7326/0003-4819-115-3-165
  4. Schlondorff D. Renal complication of nonsteroidal anti-inflammatory drugs. Kindey Int 44:643-653, 1993. https://doi.org/10.1038/ki.1993.293
  5. Abraham PA, Keane WF. Glomerular and interstitial disease induced by nonsteroidal anti-inflammatory drugs. Am J Nephrol 4:1-6, 1984. https://doi.org/10.1159/000166764
  6. Levin ML. Patterns of tubulo-interstitial damage associated with nonsteroidal anti-inflammatory drugs. Semin Nephrol 8:55-61, 1988.
  7. Lomvardias S, Pinn VW, Wadhwa ML, Koshy KM, Heller M. Nephrotic syndrome associated with sulindac. N Engl J Med 304:424, 1981.
  8. Pirson Y, van Ypersele de Strihou C. Renal side effects of nonsteroidal anti-inflammatory drugs. Am J Kidney Dis 8:338-344, 1986. https://doi.org/10.1016/S0272-6386(86)80108-1
  9. 조용균, 이규백, 김신연, 김상훈, 김향, 이상종, 박찬필, 박문향. Piroxicam($Brexin^{\circledR}$)에 의한 신증후군을 동반한 간질성 신염 1예. 대한신장학회지 17:836-840, 1998.
  10. Palmer BF. Renal complications associated with use of nonsteroidal anti-inflammatory agents. J Investig Med 43:516-533, 1995.
  11. Haas JA, Hammond TG, Granger JP, Blaine EH, Knox FG. Mechanism of natriuresis during intrarenal infusion of prostaglandins. Am J Physiol 247:F475-F479, 1984.
  12. Kirchner KA, Martin CJ, Bower JD. Prostaglandin E2, but not I2 restores furosemide response in indomethacin-treated rats. Am J Physiol 250:F980-F985, 1986.
  13. Fellner SK. Piroxicam induced acute interstitial nephritis and minimal change nephrotic syndrome. Am J Nephrol 5:142-143, 1985. https://doi.org/10.1159/000166921
  14. Bander SJ. Reversible renal failure and nephrotic syndrome without interstitial nephritis from zomepirac. Am J Kidney Dis 6:233-236, 1985. https://doi.org/10.1016/S0272-6386(85)80178-5
  15. Warren GV, Korbet SM, Schwartz MM, Lewis EJ. Minimal change glomerulopathy associated with nonsteroidal anti-inflammatory drugs. Am J Kidney Dis 13:127-130, 1989. https://doi.org/10.1016/S0272-6386(89)80130-1
  16. Morgenstern SJ, Bruns FJ, Fraley DS, Kirsch M, Borochovitz D. Ibuprofen-associated lipoid nephrosis without interstitial nephritis. Am J Kidney Dis 14:50-52, 1989. https://doi.org/10.1016/S0272-6386(89)80093-9
  17. Boerlin V, Maeglin B, Hagler W, Kuhn M, Nuesch E. Analgesic activity of propyphenazone in patients with pain following oral surgery. Eur J Clin Pharmacol 31:127-131, 1986. https://doi.org/10.1007/BF00606648
  18. Goodman Gilman A, Rall TW, Nies A, Taylor P. The pharmacological basis of therapeutics. 8th ed. New York, Macmillan, 1990.
  19. Romer D. Pharmacological evaluation of mild analgesics. Br J Clin Pharmacol 10:247S-251S, 1980. https://doi.org/10.1111/j.1365-2125.1980.tb01807.x
  20. Lowenstein J, Schacht RG, Baldwin DS. Renal failure in minimal change nephrotic syndrome. Am J Med 70:227-233, 1981. https://doi.org/10.1016/0002-9343(81)90754-3
  21. Feinfeld DA, Olesnicky L, Pirani CL, Appel GB. Nephrotic syndrome associated with use of the nonsteroidal anti-inflammatory drugs: case report and review of the literature. Nephron 37:174-179, 1984. https://doi.org/10.1159/000183239
  22. Nolasco F, Cameron JS, Heywood EF, Hicks J, Ogg C, Williams DG. Adult-onset minimal change nephrotic syndrome: a long-term follow up. Kidney Int 29:1215-1223, 1986. https://doi.org/10.1038/ki.1986.130
  23. Korbet SM, Schwartz MM, Lewis EJ. Minimalchange glomerulopathy of adulthood. Am J Nephrol 8:291-297, 1988. https://doi.org/10.1159/000167603